48, XXXX: Difference between revisions

Jump to navigation Jump to search
No edit summary
(No difference)

Revision as of 13:54, 24 June 2010

XXXX syndrome
ICD-10 Q97.1
DiseasesDB 32550

WikiDoc Resources for 48, XXXX

Articles

Most recent articles on 48, XXXX

Most cited articles on 48, XXXX

Review articles on 48, XXXX

Articles on 48, XXXX in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 48, XXXX

Images of 48, XXXX

Photos of 48, XXXX

Podcasts & MP3s on 48, XXXX

Videos on 48, XXXX

Evidence Based Medicine

Cochrane Collaboration on 48, XXXX

Bandolier on 48, XXXX

TRIP on 48, XXXX

Clinical Trials

Ongoing Trials on 48, XXXX at Clinical Trials.gov

Trial results on 48, XXXX

Clinical Trials on 48, XXXX at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 48, XXXX

NICE Guidance on 48, XXXX

NHS PRODIGY Guidance

FDA on 48, XXXX

CDC on 48, XXXX

Books

Books on 48, XXXX

News

48, XXXX in the news

Be alerted to news on 48, XXXX

News trends on 48, XXXX

Commentary

Blogs on 48, XXXX

Definitions

Definitions of 48, XXXX

Patient Resources / Community

Patient resources on 48, XXXX

Discussion groups on 48, XXXX

Patient Handouts on 48, XXXX

Directions to Hospitals Treating 48, XXXX

Risk calculators and risk factors for 48, XXXX

Healthcare Provider Resources

Symptoms of 48, XXXX

Causes & Risk Factors for 48, XXXX

Diagnostic studies for 48, XXXX

Treatment of 48, XXXX

Continuing Medical Education (CME)

CME Programs on 48, XXXX

International

48, XXXX en Espanol

48, XXXX en Francais

Business

48, XXXX in the Marketplace

Patents on 48, XXXX

Experimental / Informatics

List of terms related to 48, XXXX

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

XXXX syndrome (also called tetrasomy X, quadruple X, or 48, XXXX) is a rare chromosomal disorder caused by the presence of four X chromosomes instead of two X chromosomes, which are normally found in females. This condition occurs only in females, as there are no Y chromosomes present. Tetrasomy X was first described in 1961, and since then approximately 100 cases have been reported worldwide. Approximately 60 females have been described in medical literature with this condition.

Causes and Diagnosis

Tetrasomy X is a chromosomal aneuploidy, meaning it arises from a defect in meiosis. This can occur when homologous X chromosomes fail to separate in the formation of the egg or sperm. Tetrasomy X is usually suspected based on symptoms present in the individual and is confirmed via karyotyping, which reveals the extra X chromosomes.

Symptoms

Symptoms of tetrasomy X are highly variable, ranging from relatively mild to severe. Physically, tetrasomy X patients tend to have distinctive facial features such as epicanthal folds, flat nasal bridges, upslanting palpebral fissures, midface hypoplasia, small mouths, cleft or high arched palates, delayed or absent teeth, or enamel defects. The majority have also been reported as being longer and taller. Many also show joint and muscle tone abnormalities, including hypotonia and joint looseness in the hips. Skeletal problems may also be present, including abnormal curvatures of the spine. An informal study conducted by Tetrasomy & Pentasomy X Syndrome Information and Support found that 10% of girls had joint laxity in the hips and 20% had joint limitations in a sample size of 20 tetrasomy and pentasomy patients.

In terms of intelligence, clinical findings suggest that IQ decreases 10 to 15 points per extra X chromosome. Consequently, the average IQ scores of tetrasomy X patients are between 60 and 70.

Developmentally, tetrasomy X patients frequently show mild delays in the areas of speech development and articulation, language expression and understanding, and reading skills. Delays in motor development are also present, with walking ages ranging from 16 months to 4.5 years. About 50% of patients undergo puberty normally, whereas the other 50% experiences no puberty, partial puberty without secondary sexual characteristics, or complete puberty with menstrual irregularities and/or early menopause (possibly as early as the teens). Medical literature reports four tetra-X pregnancies, two healthy, one with trisomy 21, one stillborn with omphalocele.

In terms of internal organ systems, tetrasomy X patients may have abnormal vision, hearing, circulatory systems, kidneys, or nervous systems. Disorders of the eye include myopia, nystagmus, coloboma, microphthalmus, or optic nerve hypoplasia. In terms of hearing, patients are more prone to ear infections, sound blockage, or nerve abnormalities. Several cardiac defects have also been reported, including ventricular/atrial septal defects, atresia, hypoplastic right heart syndrome, patent ductus arteriosus, and conotruncal or valvular cardiac defects. Tetrasomy X patients also appear to be more prone to seizure activity, although there is no documented abnormalities in brain function or structure when analyzed using an ECG or MRI.

Treatment and Prognosis

The general prognosis for girls with tetrasomy X is relatively good. Due to the variability of symptoms, some tetrasomy X girls are able to function normally, whereas others will need medical attention throughout their lives. Traditionally, treatment for tetrasomy X has been management of the symptoms and support for learning. Most girls are placed on estrogen treatment to induce breast development, arrest longitudinal growth, and stimulate bone formation to prevent osteoporosis. Speech, occupational, and physical therapy may also be needed depending on the severity of the symptoms.

See also

References

  • Linden MG, Bender BG, Robinson A (1995). "Sex chromosome tetrasomy and pentasomy". Pediatrics. 96 (4 Pt 1): 672–82. PMID 7567329.
  • Rooman RP, Van Driessche K, Du Caju MV (2002). "Growth and ovarian function in girls with 48,XXXX karyotype--patient report and review of the literature". J Pediatr Endocrinol Metab. 15 (7): 1051–5. PMID 12199336.

External links

Template:Chromosomal abnormalities Template:SIB


Template:WS